We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency

    Adenosine deaminase (ADA) deficiency leads to severe combined immunodeficiency (SCID). Previous clinical trials showed that autologous CD34 + cell...

    Maddalena Migliavacca, Federica Barzaghi, ... Maria Pia Cicalese in Nature Medicine
    Article 14 February 2024
  2. Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer

    Background

    In patients with metastatic castration-resistant prostate cancer, darolutamide was well tolerated for 25 months, but minimal long-term...

    Robert Hugh Jones, Karim Fizazi, ... Egils Vjaters in Prostate Cancer and Prostatic Diseases
    Article Open access 26 October 2023
  3. Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease

    The synthetic tetrahydrocannabinol-analog nabilone improved non-motor symptoms (NMS) in Parkinson’s disease (PD) patients in a placebo-controlled,...

    Marina Peball, Beatrice Heim, ... Klaus Seppi in npj Parkinson's Disease
    Article Open access 15 March 2024
  4. Long-term efficacy and safety of leflunomide combined with low-dose prednisone in treatment of myasthenia gravis: a retrospective study

    Background

    Leflunomide and low-dose prednisone (0.25 mg/kg/day) (LEF + Pred) rapidly improved the clinical symptoms of myasthenia gravis (MG)...

    Li Qiu, Pei Chen, ... Weibin Liu in Acta Neurologica Belgica
    Article 01 September 2023
  5. Long-Term Constant Subcutaneous Drug Administration

    In this chapter, a long-term drug delivery system for preclinical therapeutic research is introduced. By using a subcutaneously implanted ALZET®...
    Shuang Liu, Maya Miyoshi in Rheumatoid Arthritis
    Protocol 2024
  6. Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke

    Purpose

    Cilostazol is a widely used antiplatelet drug for secondary stroke prevention in Asia, but its comparison with clopidogrel is not well...

    Yu Jeong Lee, Nam Kyung Je in European Journal of Clinical Pharmacology
    Article 13 June 2023
  7. Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model

    Duchenne muscular dystrophy (DMD) is a lethal disease caused by X-linked mutations in the dystrophin gene. Dystrophin deficiency results in...

    Maria Siemionow, Sonia Brodowska, ... Ahlke Heydemann in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 17 August 2022
  8. Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

    Patients with Wiskott–Aldrich syndrome (WAS) lacking a human leukocyte antigen-matched donor may benefit from gene therapy through the provision of...

    A. Magnani, M. Semeraro, ... M. Cavazzana in Nature Medicine
    Article Open access 24 January 2022
  9. Long-term continuous monitoring of arrhythmias in pigs with insertable cardiac monitors

    Arrhythmia detection is essential when assessing the safety of novel drugs and therapies in preclinical studies. Many short-term arrhythmia...

    Jonna Airaksinen, Satu Siimes, ... Seppo Ylä-Herttuala in Pflügers Archiv - European Journal of Physiology
    Article Open access 04 May 2024
  10. The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring

    The next generation of surgical robotics is poised to disrupt healthcare systems worldwide, requiring new frameworks for evaluation. However,...

    Hani J. Marcus, Pedro T. Ramirez, ... Arsenio Paez in Nature Medicine
    Article 19 January 2024
  11. COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

    Purpose

    Mixed cryoglobulinemia syndrome (MCs) is a rare immunoproliferative systemic disorder with cutaneous and multiple organ involvement. Our...

    Laura Gragnani, Marcella Visentini, ... Clodoveo Ferri in Journal of Clinical Immunology
    Article 16 February 2023
  12. Long-term follow up of alemtuzumab-treated patients: a retrospective study in a Belgian tertiary care center

    Background

    Pivotal studies have reported a significant proportion of patients achieving no evidence of disease activity (NEDA) after 2 cycles of...

    Vincent van Pesch, Andreea-Raluca Hanganu, Souraya El Sankari in Acta Neurologica Belgica
    Article 15 April 2024
  13. Long-term outcomes after particle radiation therapy in patients with nasopharyngeal adenoid cystic carcinoma

    Background

    Nasopharyngeal adenoid cystic carcinoma (NACC) is a relatively rare salivary gland tumor that is generally associated with poor outcomes....

    Weixu Hu, Jiyi Hu, ... Lin Kong in BMC Cancer
    Article Open access 18 June 2024
  14. The Biological Effects of Long-Term Static Magnetic Field Exposure

    Although in most cases, people are exposed to static magnetic fields (SMFs) for just a short period of time, there are increasing situations where...
    Chapter 2023
  15. Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study

    Background

    PF-05280014 was compared with trastuzumab sourced from the European Union (trastuzumab-EU), each plus paclitaxel, as first-line treatment...

    Rubi K. Li, Eriko Tokunaga, ... Oleg Lipatov in BioDrugs
    Article Open access 01 January 2022
  16. Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-DΔNΔC gene therapy eight-year follow-up of phase I KAT301 study

    In phase I KAT301 trial, intramyocardial adenovirus-mediated vascular endothelial growth factor -D ΔNΔC (AdVEGF-D) gene therapy (GT) resulted in a...

    Aleksi J. Leikas, Iiro Hassinen, ... Juha E. K. Hartikainen in Gene Therapy
    Article Open access 01 October 2021
  17. Early Environment and Telomeres: a Long-Term Toxic Relationship

    Purpose of Review

    Telomere length (TL) shortening is a hallmark of biological aging. While studies have extensively focused on the impact of...

    José Francisco Herrera-Moreno, Diddier Prada, Andrea A. Baccarelli in Current Environmental Health Reports
    Article 22 March 2023
  18. Short-term and long-term outcomes of patients with gastric cancer during versus before the COVID-19 pandemic: cohort study using propensity score matching method

    Background

    The negative effects of the novel coronavirus disease 2019 (COVID-19) pandemic on patients with gastric cancer are poorly understood. This...

    Yong Sun, Chao Chen, ... Enhong Zhao in BMC Cancer
    Article Open access 28 September 2023
  19. Long-term benefits of hematopoietic stem cell-based macrophage/microglia delivery of GDNF to the CNS in a mouse model of Parkinson’s disease

    Glial cell line-derived neurotrophic factor (GDNF) protects dopaminergic neurons in various models of Parkinson’s disease (PD). Cell-based GDNF gene...

    Guo Ge, Barath P. Sivasubramanian, ... Senlin Li in Gene Therapy
    Article 16 April 2024
  20. A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark

    Many individuals who refuse COVID-19 vaccination have concerns about long-term side effects. Here, we report findings on self-reported symptoms from...

    Elisabeth O’Regan, Ingrid Bech Svalgaard, ... Anders Hviid in npj Vaccines
    Article Open access 04 March 2024
Did you find what you were looking for? Share feedback.